News
Results published in the peer-reviewed journal Investigational New DrugsStudy in heavily pre-treated patients with solid tumor indications who had progressed on prior immune checkpoint ...
GOTHENBURG, SE / ACCESS Newswire / May 6, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, May 6, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback